Drug Information

Drug General Information
Drug ID
D04ZIZ
Former ID
DNCL002340
Drug Name
DMUC-5754A
Drug Type
Antibody
Indication Fallopian tube cancer; Peritoneal cancer; Ovarian cancer [ICD9: 140-229, 183.2, 221.0, 183; ICD10:C57, D28, C56] Phase 1 [523430]
Company
Genentech
Target and Pathway
Target(s) Mucin 16 Target Info [532331]
References
Ref 523430ClinicalTrials.gov (NCT01335958) Safety and Pharmacokinetics of DMUC5754A Administered Intravenously to Patients With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer. U.S. National Institutes of Health.
Ref 532331Maturing antibody-drug conjugate pipeline hits 30. Nat Rev Drug Discov. 2013 May;12(5):329-32.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.